Journal of Immunology Research

Journal of Immunology Research / 2018 / Article

Review Article | Open Access

Volume 2018 |Article ID 6784971 | 9 pages | https://doi.org/10.1155/2018/6784971

Silicone-Induced Granuloma of Breast Implant Capsule (SIGBIC): Histopathology and Radiological Correlation

Academic Editor: Theresa Hautz
Received13 Apr 2018
Revised29 Jun 2018
Accepted14 Jul 2018
Published20 Sep 2018

Abstract

Currently, attention has been given to complications related to breast implants, especially due to the presence of anaplastic large cell lymphoma (ALCL) related to silicone implants. Many manuscripts attempt to associate silicone presence with clinical complaints reported by patients, while others try to demonstrate the mechanisms of silicone bleeding by permeability loss of breast implant surfaces. There also are reports of foreign body type reactions from implant fibrous capsule to silicone corpuscles. However, there seems to be no study that correlates the clinical, radiological, and histological correlations of these lesions. The objective of this review is to correlate radiological findings of silicone-induced granuloma of breast implant capsule (SIGBIC) from breast MRI (BMRI) scans and complementary findings of ultrasound (US) and positron emission tomography (PET) scan, and its histology originated from surgical breast implant capsulectomy. To make this correlation possible, we divided SIGBIC into three radiological findings: (1) intracapsular SIGBIC, (2) SIGBIC with extracapsular extension, and (3) mixed SIGBIC associated with seroma. Our experience demonstrates histological-radiological correlation in SIGBIC diagnosis. Knowledge of these findings may demonstrate its real importance in terms of public health and patient management. We believe that SIGBIC is currently underdiagnosed by lack of training, guidance, and management in our clinical practice.

1. Introduction

Many complications are reported inherent to breast silicone implants, such as late seroma, infections, rejections, intra- and extracapsular ruptures, contractures, and more recently, anaplastic large cell lymphoma (ALCL) [1]. However, the determining factors to develop these complications are still a black box. Surprisingly, one of the most frequent BMRI findings at our service related to silicone implant complications is a granuloma induced by free silicone granules (SIGBIC), present in about 27.1% of cases.

This manuscript is based on data analysis obtained from an observational prospective study for breast implant evaluation in patients referred to a breast magnetic resonance scan. The study was approved by our Institutional Ethics Research Committee with an informed consent term signed by all patients. Patients with suggestive SIGBIC BMRI findings were recalled for additional ultrasonography and PET scan. Final diagnosis was confirmed by percutaneous biopsy or by surgical capsulectomy.

Since February 2017, 2891 BMRI have been analyzed. Of these, 830 patients were referred for breast implant evaluation. 27.1% of the implants presented BMRI signs of SIGBIC, of which 12.7% had associated intracapsular seroma and 3.3% had signs of extracapsular involvement.

At first, the study was designed to investigate the incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Since its beginning, we have not found any case of BIA-ALCL. However, we diagnosed a type of intracapsular lesion not reported in previous studies, where the imaging and clinical findings were very similar to BIA-ALCL. When correlating these findings to histological results, a granuloma induced by free silicone particles in fibrous capsule was found. Many of these cases were not diagnosed in the first histological report, where pathologists ignored to report free silicone presence. After the histological revision to investigate the presence of free silicone, SIGBIC was confirmed.

The lack of manuscripts in literature reporting SIGBIC imaging findings is especially due to the protocols adopted for BMRI breast implant evaluation, where contrast media is generally not used. This results in underdiagnoses of SIGBIC, especially with the differential diagnosis of late seroma [2].

More recent manuscripts still question whether BIA-ALCL would be a true lymphoma, assuming the possibility that it could be due to an immune response. In this context, a recent article was published which reported spontaneous regression of BIA-ALCL in 2 patients [3, 4].

The objective of this pictorial review is to illustrate how to describe the main imaging findings of silicone-induced granuloma of breast implant capsule (SIGBIC) and to correlate with cytopathology results.

2. SIGBIC Physiopathology

2.1. Breast Implant Surface Fatigue

It is speculated that any breast implant, whether saline or silicone, should bleed silicone corpuscles over time. Some factors can accelerate this, such as trauma determining microfractures, temperature or pressure exposure, ultraviolet radiation, oxidation, and chemical reactions.

When permeability of elastomer is impaired, the physiological seroma that lies in the space between the elastomer surface and the fibrous capsule reacts and transports the resulting polydimethylsiloxane compound from the implant surface that will encounter the fibrous capsule [1, 5] (Figure 1).

2.2. Fibrous Capsule

Fibrous capsule consists of dense fibrosis, with an inner surface lined by pseudosynovia, consisting of a layer of histiocytes. When silicone particles get in contact with fibrous capsule, whatever the mechanism, an immune response could be generated from the host. Such response may be a silicone-induced granuloma, which may vary in intensity [6].

Fibrous capsule acts as physiological protection barrier against products from intracapsular environment. Blood supply to this intracapsular environment is restricted. This results in an indolent mass growth which predicts the good prognosis of SIGBIC when restricted to fibrous capsule. However, when fibrous capsule ruptures and exposes its contents to extracapsular space, the immune reaction becomes more exuberant. In these cases, silicone exposure can trigger a systemic immune reaction [6].

2.3. Immunological Response to Silicone

Some patients will develop an autoimmune reaction to silicone components, known as silicone implant incompatibility syndrome (SIIS). This immune response may range from indolent to more aggressive degrees [6, 7] (Figure 2).

According to this immunological modulation, giant cells and lymphocyte relation will vary according to each host, from light when there is predominance of giant cells to more aggressive when there is a major lymphocyte component. At this point, great correlation between ALCL and SIGBIC is observed. However, ALCL has T lymphocyte CD30 positive to immunohistochemistry reaction [5] (Figure 3).

2.4. Silicone Particles

Silicone has several appearances at optical microscopy, maybe refractile but not polarized, appearing brighter and shinier than the normal tissue. If polarizable material is present, it is another type of material, not silicone. The two most frequent findings at histology are extracellular and intracellular silicones [7].

Extracellular silicone has clear spaces partially occupied by refractile (but not polarized) material amid giant cells, histiocytes, and lymphocyte appearances. On the other hand, intracellular silicone appears as light spheres that vary in size, located within histiocytes that sometimes looks like lipoblasts [7].

Histologically, SIGBIC is formed by extracellular and/or intracellular silicone, numerous histiocytes, chronic granulomatous inflammatory infiltrate with multinucleated giant cells, and infiltrate of mixed lymphocytes—T and B without atypia.

2.5. Immunohistochemistry

Immunohistochemistry profile may be used as an auxiliary tool to confirm the diagnosis of SIGBIC, especially to determine the differential diagnosis with ALCL. The diagnostic tests performed are (i)CD3: T lymphocyte marker(ii)CD20: B lymphocyte marker(iii)CD30: marker of Hodgkin’s disease, ALCL, and embryonal carcinoma(iv)CD68: marker of macrophages, monocytes, and Langerhans cells

As a rare differential diagnosis, ALCL reveals infiltrate of atypical lymphocytes with pleomorphic nucleus and 1 or more nucleoli. These lymphocytes may be arranged diffusely or in an aggregated distribution at the fibrous capsule. The mitotic index is usually higher, and necrosis may be present. Virtually, all these atypical cells have CD30 expression and negativity to anaplastic lymphoma kinase (ALK) [8].

3. Clinical Findings

Most SIGBICS are incident findings. The main clinical symptom is breast stiffening. Additional symptoms are skin rash, arthralgia, pruritus, and asthenia. These findings are similar to those described by de Faria Castro Fleury et al. where SIIS cases were compared over a 30-year period [9].

Patients usually present physical limitations to practice their daily activities, and some of them are submitted to specialized treatment with rheumatologists.

4. Histological-Radiological Correlation

For diagnostic and classification purposes, it was chosen to classify the SIGBIC according to BMRI findings. In this context, SIGBIC was divided into 3 categories: (1)Intracapsular SIGBIC(2)SIGBIC with extracapsular extension(3)Mixed SIGBIC associated with seroma

4.1. Intracapsular SIGBIC

These patients usually seek the breast specialist with a clinical complaint of capsular contracture, usually manifests as slow growth lesions. Symptoms may regress after use of anti-inflammatory and/or corticosteroid therapy. Definitive treatment is withdrawal of the causal factor, removing the implant and performing capsulectomy.

4.1.1. Radiological Findings

Radiological SIGBIC findings were first reported by our group recently. To reach the definitive diagnosis, it is necessary for a trained radiologist to investigate the pathognomonic BMRI findings of SIGBIC. In addition to trained radiologists, it is imperative to use contrast medium and late dynamic sequences due to the difficulty of contrast reaching intracapsular environment [8].

When free silicone particles reach the implant fibrous capsule, a granuloma forms. This granuloma will present in BMRI as an intracapsular high signal in T2-weighted sequences. Most often, it exerts as external compressive effect on the implant surface. In these cases, there are no radiological signs suggestive of implant rupture. Usually, these lesions are erroneously classified as late seromas, especially by lack of use of contrast medium. SIGBIC can only be confirmed in the late dynamic sequences where late enhancement confirms the solid nature of the lesion [8, 10].

Another BMRI finding that allows the diagnosis is the black-drop sign. The black-drop sign corresponds to silicone granules within implant fibrous capsule, where marked low signal foci may be found. It is worth to mention that all cases of SIGBIC presented signs of capsular contracture.

(1) BMRI. Breast MRI is the gold standard for diagnosis. The criteria for diagnosing SIGBIC described by our group are [8] (Figures 4(a) and 4(b)) (i)intracapsular mass with hypersignal at T2-weighted sequences(ii)black-drop signal in fibrous capsule(iii)late contrast enhancement at dynamic sequences, usually at after 4-minute phases

(2) US. Complementary ultrasound scan may aid the diagnosis of SIGBIC. The main finding is an intracapsular heterogeneous mass, which has the appearance of a snowstorm type, related to free silicone. Doppler scan will generally not present vascularization, and elastography is hard (Figure 4(c)).

(3) PET Scan. PET scan can assist in determining whether there is involvement of the extracapsular compartment. When intracapsular, PET scan scanning tends to be negative (Figure 4(d)).

4.1.2. Histological Findings

Predominance of extracapsular silicone with a lower aggregate lymphocyte population is observed, usually found in fibrous capsule focal thicket areas. It can be associated with a moderate chronic foreign body inflammatory process type and rare xanthomatous histiocytes. No individualized lymphocytes dispersed by the fibrous capsule or atypical cells are observed (Figures 5(a) and 5(b)).

4.2. SIGBIC with Extracapsular Extension

SIGBIC with extracapsular extension is related to fibrous capsule invasion. It usually has edema of the breast tissue at the periphery of the prosthesis. The symptomatology is more exuberant, where a recent history of volumetric breast enlargement, accompanied by stiffness and local phlogistic signs, are often reported.

4.2.1. Radiological Findings

(1) BMRI. In addition to the solid component reported, small seroma may be present. Capsular invasion is demonstrated by involvement of the breast tissue at the fibrous capsule periphery. Lymph nodes with siliconomas can also be visualized.

As there is loss of fibrous capsule barrier and host response to the foreign body, earlier contrast enhancement of the involved areas is observed (Figures 6(a) and 6(b)).

(2) US. Most often, it is possible to find inner texture changes of the breast implants, with areas of a snowstorm type at fibrous capsule. Peripheral increased vascularization may be observed (Figure 6(c)).

(3) PET Scan. With the breakage of the fibrous capsule protection, uptake of radioisotope by granuloma is seen. Lymph nodes in the axillary chains and/or in distant chains may be found (Figure 6(d)).

4.2.2. Histological Findings

At macroscopy, SIGBIC will appear as masses attached to the fibrous capsule inner surface, with firm-elastic consistence and yellow-whitish color. Another indication of its presence is breast implant color change, from white to yellow, known as a cloudy implant (Figure 7(a)).

SIGBIC with extracapsular extension has association of intracellular and extracellular silicones, with predominance of the extracellular type. Generally, there is a moderate chronic inflammatory process, foreign body-like reaction, and moderate xanthomatous histiocyte amount.

It is distinguished from the intracapsular SIGBIC by the presence of multiple aggregates of mature and nonatypical lymphocytes (immunophenotypes B and T), some of which have germinal centers. There is still a dense diffuse lymphocyte infiltration without atypia by the capsule.

Associated findings, capsular calcifications, and the presence of fibro necrotic material may be found (Figures 7(b)7(d)).

4.3. Mixed SIGBIC Associated with Seroma

Symptomatology is quite exuberant in these cases, where abrupt volumetric increase of the affected breast accompanied by phlogistic signs is reported.

4.3.1. Radiological Findings

(1) BMRI. In addition to the findings described in SIGBIC with extracapsular extension, large seroma formation is observed. Seroma must have a thick serous content, with a heterogeneous signal in the T2-weighted sequences. After the injection of the contrast medium, there may be enhancement of coarse septa which communicate with the fibrous capsule (Figures 8(a) and 8(b)).

(2) US. Seroma is easy to identify with ultrasound and is often associated with debris. The mass content can also be visualized and usually has increased vascularization at Doppler scans (Figures 8(c)).

4.3.2. Histological Findings

Despite seroma formation, histology of mass content is very similar to the extracapsular extension type, with intra- and extracellular silicones. However, in these cases, the intracellular silicone predominates (Figures 9(a)9(c)).

Seroma cytology may demonstrate degenerate histiocytes and rare small lymphocytes without atypia (Figures 10).

5. Conclusion

Our experience demonstrates histological-radiological correlation to SIGBIC diagnosis (Table 1). Knowledge of these findings by radiologists and pathologists improve its diagnosis. We believe that SIGBIC is currently underdiagnosed by lack of training, guidance, and management at our clinical practice.


SIGBICBMRIHistology

(1) Intracapsular(i) Restricted to intracapsular space
(ii) Mass with hypersignal at T2-weighted sequences
(iii) Black-drop signal
(iv) Late contrast enhancement
(i) Extracellular silicone
(ii) Lower population of aggregate lymphocytes
(iii) Moderate chronic inflammatory process

(2) Extracapsular extension(i) Same findings from intracapsular
(ii) Pericapsular edema
(iii) Lymph node involvement
(iv) Early contrast enhancement of the extracapsular content
(i) Extracellular and intracellular silicone
(ii) Predominance of extracellular silicone
(iii) Germinal centers of lymphocytes
(iv) Diffuse infiltration by lymphocytes at the fibrous capsule

(3) Mixed with seroma(i) Same findings from the others
(ii) Voluminous seroma
(i) Extracellular and intracellular silicone
(ii) Predominance of intracellular silicone
(iii) More severe infiltration by lymphocytes at the fibrous capsule
(iv) Seroma of histiocytes and lymphocytes

Abbreviations

SIGBIC:Silicone-induced granuloma of breast implant capsule
ALCL:Anaplastic large cell lymphoma
BMRI:Breast magnetic resonance imaging
US:Ultrasound
PET:Positron emission tomography
PDMS:Polydimethylsiloxane
SIIS:Silicone implant incompatibility syndrome
ALK:Anaplastic lymphoma kinase.

Ethical Approval

The study was approved by the institutional ethical committee.

Informed consent was obtained from all of the participants.

Disclosure

The authors guarantee that the article has been submitted only to Journal of Immunology Research.

Conflicts of Interest

The authors declare that no conflicts of interest are associated with this research. The authors also declare that this study has no conflicts of interest with previously published studies.

References

  1. A. T. Shah and B. B. Jankharia, “Imaging of common breast implants and implant-related complications: a pictorial essay,” Indian Journal of Radiology and Imaging, vol. 26, no. 2, pp. 216–225, 2016. View at: Publisher Site | Google Scholar
  2. ACR, ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas, American college of Radiology, Reston, VA, USA, 5th edition, 2003, American College of Radiology, “ACR BI-RADS® - Magnetic Resonance”.
  3. E. de Faria Castro Fleury, “Additional risk factors for breast implant-associated anaplastic large cell lymphoma,” JAMA Surgery, vol. 153, no. 8, pp. 780-781, 2018. View at: Publisher Site | Google Scholar
  4. D. Fleming, J. Stone, and P. Tansley, “Spontaneous regression and resolution of breast implant-associated anaplastic large cell lymphoma: implications for research, diagnosis and clinical management,” Aesthetic Plastic Surgery, vol. 42, no. 3, pp. 672–678, 2018. View at: Publisher Site | Google Scholar
  5. E. M. Taylor, R. Sackeyfio, and R. T. Grant, “Clear to cloudy: silicone breast implants in vivo,” Aesthetic Plastic Surgery, vol. 38, no. 4, pp. 827–829, 2014. View at: Publisher Site | Google Scholar
  6. J. W. Cohen Tervaert and R. M. Kappel, “Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome),” Immunologic Research, vol. 56, no. 2-3, pp. 293–298, 2013. View at: Publisher Site | Google Scholar
  7. M. J. L. Colaris, M. de Boer, R. R. van der Hulst, and J. W. Cohen Tervaert, “Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature,” Immunologic Research, vol. 65, no. 1, pp. 120–128, 2017. View at: Publisher Site | Google Scholar
  8. E. de Faria Castro Fleury, A. C. Gianini, V. Ayres, L. C. Ramalho, R. O. Seleti, and D. Roveda, “Breast magnetic resonance imaging: tips for the diagnosis of silicone-induced granuloma of a breast implant capsule (SIGBIC),” Insights Imaging, vol. 8, no. 4, pp. 439–446, 2017. View at: Publisher Site | Google Scholar
  9. E. de Faria Castro Fleury, M. M. Rêgo, L. C. Ramalho et al., “Silicone-induced granuloma of breast implant capsule (SIGBIC): similarities and differences with anaplastic large cell lymphoma (ALCL) and their differential diagnosis,” Breast Cancer: Targets and Therapy, vol. 9, pp. 133–140, 2017. View at: Publisher Site | Google Scholar
  10. E. de Faria Castro Fleury, A. C. Gianini, V. Ayres, L. C. Ramalho, D. Roveda, and M. de Oliveira, “Application of breast ultrasound elastography to differentiate intracapsular collection from silicone-induced granuloma of breast implant capsule complementarily to contrast-enhanced breast magnetic resonance imaging,” Breast Cancer: Basic and Clinical Research, vol. 11, pp. 1–5, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 Eduardo de Faria Castro Fleury et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

3984 Views | 657 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.